Opendata, web and dolomites

HEATSENS_S

Lab-on-a-chip microfluidic device based on plasmonic driven thermal nanobiosensing for rapid detection of Salmonella in chicken meat.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HEATSENS_S project word cloud

Explore the words cloud of the HEATSENS_S project. It provides you a very rough idea of what is the project "HEATSENS_S" about.

2019    strategy    money    position    19hrs    right    enter    market    exclusive    first    negative    tests    nanoimmunotech    sensitive    customers    poultry    affordable    commercial    industry    limit    huge    gold    sales    specifications    times    positive    smei    biosensors    price    human    final    company    medium    analytes    niches    innovation    forecasted    biosensor    acknowledge    lab    simpler    18    feasibility    thanks    financial    consists    viability    competitors    easily    once    stakeholders    faster    turnover    pay    nit    salmonella    months    point    cheaper    channel    detect    meat    proved    nanoprisms    consumables    million    commercialisation    expand    chicken    time    inflection    solid    collaborated    exploiter    contacts    business    trl6    model    detection    launching    food    day    device    saved    heatsens    nanotechnology    pole    profit    load    attomolar    sole    ready    global    prototype    nanobiotechnology    ultrasensitive    multiplying    reported    launch    safety   

Project "HEATSENS_S" data sheet

The following table provides information about the project.

Coordinator
NANOIMMUNOTECH SL 

Organization address
address: EDIFICIO CITEXVI C FONTE DAS ABELLE SN CAMPUS UNIVERSITARIO DE VIGO
city: VIGO PONTEVEDRA
postcode: 36310
website: www.nanoimmunotech.eu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://nanoimmunotech.eu/en/Projects/2017-06-29-14-01-01/HEATSENS-S
 Total cost 1˙930˙087 €
 EC max contribution 1˙351˙061 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2019-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NANOIMMUNOTECH SL ES (VIGO PONTEVEDRA) coordinator 1˙351˙061.00

Map

 Project objective

NANOIMMUNOTECH (NIT) is a nanobiotechnology Company which is the sole exploiter of an exclusive ultrasensitive biosensor nanotechnology, called HEATSENS. Thanks to the innovation of using gold nanoprisms, it is able to detect analytes with a low level of detection (attomolar detection limit, one million times more sensitive than competitors), in a faster, cheaper and simpler way than current methodologies do.

The aim of this Project is to implement HEATSENS technology in a specific biosensor product: HEATSENS_S, a biosensor able to detect Salmonella in chicken meat on the same working day both for positive and negative results, at an affordable price for customers (where current methodologies take not less than 19hrs). It means a huge impact for the poultry industry, in terms of time and money saved, and food safety.

HEATSENS_S is already implemented on a lab prototype (TRL6), and its commercial, technical and financial viability was proved and reported on the SMEI-1 Feasibility study. Relevant final customers (who acknowledge to be willing to pay for the product and collaborated on the product specifications) and key stakeholders, are also involved in the Project. These contacts will be expand during SMEI-2 in order to set a solid commercialisation channel.

HEATSENS_S will be market ready in 18 months’ time, right after the end of the Project. It will be the inflection point in NIT profit, turnover and human resources trends, leading its medium and long term business strategy and increasing NIT Company value up to 30 times, multiplying by 4 their sales from 2019. All in all, once that this first launch is on the market, NIT will easily enter different biosensor market niches by extending HEATSENS_S. The business model consists on a device in which consumables for the detection of different analytes (Tests) must be load. Thus, further Tests launching is forecasted in order to position HEATSENS and NIT at the pole position of the global biosensors market.

 Deliverables

List of deliverables.
CE Marking documentation set Documents, reports 2019-08-30 13:20:54

Take a look to the deliverables list in detail:  detailed list of HEATSENS_S deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEATSENS_S" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEATSENS_S" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

Gri3D (2018)

The industrialization and market entry of a novel bioengineered hydrogel grid to standardize stem cell cultures for precision medicine.

Read More  

NAS (2018)

Nexilis augmentation system

Read More  

PLUGandFLOW (2017)

VessConnect “Plug Flow” innovative technology providing patients a safer, more effective and less costly procedure for vascular anastomosis

Read More